ALB and cholangiocarcinoma: We also observed increased levels of carbohydrate antigen 19-9 (CA19-9) and γ-glutamyltransferase (γ-GT) and decreased levels of albumin, markers of hepatobiliary disease and of unfavourable prognosis in CCA, in the LINC00313 cluster (Fig. 8F).